Garo Armen
Jun 28, 2025, 15:15
Garo Armen Shares a Personal Story Driving Agenus’ Mission in Cancer Care
Agenus posted on LinkedIn:
“At Agenus, we know firsthand that better cancer treatments are urgently needed. Current options for colorectal and rectal cancers are often invasive, taxing, and can lead to lasting complications—leaving patients with a diminished quality of life.
In this video, Agenus CEO Dr. Garo Armen shares a deeply personal story about a close friend whose life was extended by current therapies, but whose final months were marked by suffering. It’s experiences like these that fuel Dr. Armen’s commitment—and our company’s mission—to bring forward more effective, targeted, and humane treatment options for patients and their families.
This National Cancer Survivor Month, we reaffirm our dedication to transforming outcomes in cancer care with innovative immuno-oncology approaches designed to improve both survival and quality of life.
Watch the video below and visit our website to learn more about how we’re supporting patients.”
More posts featuring Agenus on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 28, 2025, 16:07
Jun 28, 2025, 15:34
Jun 28, 2025, 15:15
Jun 28, 2025, 15:15
Jun 28, 2025, 14:41